Andrew L. Price Sells 5,042 Shares of Encompass Health Co. (NYSE:EHC) Stock

Encompass Health Co. (NYSE:EHC) CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Encompass Health Stock Performance

NYSE EHC opened at $100.91 on Friday. The stock has a market cap of $10.17 billion, a PE ratio of 22.62, a P/E/G ratio of 1.18 and a beta of 0.90. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a twelve month low of $73.02 and a twelve month high of $104.55. The stock has a fifty day simple moving average of $95.97 and a 200-day simple moving average of $95.52.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. Equities analysts anticipate that Encompass Health Co. will post 4.76 earnings per share for the current year.

Hedge Funds Weigh In On Encompass Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in Encompass Health by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company’s stock valued at $960,817,000 after acquiring an additional 138,196 shares during the period. Invesco Ltd. boosted its holdings in Encompass Health by 3.3% during the 4th quarter. Invesco Ltd. now owns 5,536,251 shares of the company’s stock valued at $511,273,000 after acquiring an additional 176,135 shares during the period. State Street Corp boosted its holdings in Encompass Health by 0.7% during the 3rd quarter. State Street Corp now owns 3,025,769 shares of the company’s stock valued at $292,410,000 after acquiring an additional 21,329 shares during the period. Alliancebernstein L.P. boosted its holdings in Encompass Health by 6.0% during the 4th quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company’s stock valued at $191,799,000 after acquiring an additional 117,617 shares during the period. Finally, FMR LLC boosted its holdings in Encompass Health by 0.8% during the 4th quarter. FMR LLC now owns 1,973,846 shares of the company’s stock valued at $182,285,000 after acquiring an additional 15,831 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

EHC has been the subject of several recent research reports. William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. KeyCorp increased their price objective on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. Royal Bank of Canada reissued an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research note on Tuesday. StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Barclays increased their price objective on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. Ten analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.